Yüklüyor......
Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis
mRNA-based SARS-CoV-2 vaccines offer a preventive strategy against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections that is of interest in the care of patients on hemodialysis (HDP). We measured humoral immune responses in 72 HDP after standard vaccination with two doses of th...
Kaydedildi:
| Yayımlandı: | Vaccines (Basel) |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8070660/ https://ncbi.nlm.nih.gov/pubmed/33918085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9040360 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|